In the U.S., Alzheimer’s clinical trials are largely limited to fluent English speakers, which leaves millions of patients without the opportunity to participate and scientists without diverse data.
(Image credit: Richard Bailey/Getty Images)
Language Barrier Means Millions Of Elderly Can’t Access Alzheimer’s Trials
